August 24, 2026
- October 14 Webinar: Navigating the FDA Bayesian Draft Guidance: Design, Analysis, and Review Considerations
August 21, 2026
- CDER Statement: FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug Development
- Final Guidance: Evaluation of Therapeutic Equivalence
This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.
